Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.081.330.590.840.75

What is the latest Working Capital/Sales ratio of GLAND PHARMA ?

The latest Working Capital/Sales ratio of GLAND PHARMA is 1.08 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.08
Mar20241.33
Mar20230.59
Mar20220.84
Mar20210.75

How is Working Capital/Sales of GLAND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.08
-18.80
Mar2024 1.33
125.42
Mar2023 0.59
-29.76
Mar2022 0.84
12.00
Mar2021 0.75 -

Other Financial Ratios of GLAND PHARMA


Compare Working Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,303.6 Cr 8.2% 4.9% 2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹387,792.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹159,986.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹127,126.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,700.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,868.0 Cr 5.3% 7.9% -2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8.2%

4.9%

2%

SENSEX

1.5%

1.6%

0.4%


You may also like the below Video Courses